Juxtaglomerular apparatus-mediated homeostatic mechanisms: therapeutic implication for chronic kidney disease

References

• Chebib FT, Torres VE. Autosomal dominant polycystic kidney disease: core curriculum 2016. Am J Kidney Dis. 2016;67(5):792–810. doi: 10.1053/j.ajkd.2015.07.037
   PubMed Web of Science ®Google Scholar
• Grantham JJ, Torres VE, Chapman AB, et al. Volume progression in polycystic kidney disease. N Engl J Med. 2006;354(20):2122–2130. doi: 10.1056/NEJMoa054341
   PubMed Web of Science ®Google Scholar
• Irazabal MV, Rangel LJ, Bergstralh EJ, et al. Imaging classification of autosomal dominant polycystic kidney disease: a simple model for selecting patients for clinical trials. J Am Soc Nephrol. 2015;26(1):160–172. doi: 10.1681/ASN.2013101138
   PubMed Web of Science ®Google Scholar
• Torres VE, Chapman AB, Devuyst O, et al. Tolvaptan in patients with autosomal dominant polycystic kidney disease. N Engl J Med. 2012;367(25):2407–2418. doi: 10.1056/NEJMoa1205511
   PubMed Web of Science ®Google Scholar
• Torres VE, Chapman AB, Devuyst O, et al. Multicenter, open-label, extension trial to evaluate the long-term efficacy and safety of early versus delayed treatment with tolvaptan in autosomal dominant polycystic kidney disease: the TEMPO 4: 4 Trial. Nephrol Dial Transplant. 2018;33(3):477–489. doi: 10.1093/ndt/gfx043
   PubMed Web of Science ®Google Scholar
• Thurau K, Schnermann J. Die Natriumkonzentration an den Macula densa-Zellen als regulierender Faktor für das Glomerulumfiltrat (Mikropunktionsversuche) [The sodium concentration in the macula densa cells as a regulating factor for glomerular filtration (micropuncture experiments)]. Klin Wochenschr. 1965;43:410–413. German. doi: 10.1007/BF01483845
   PubMedGoogle Scholar
• Schnermann J, Briggs JP. Synthesis and secretion of renin in mice with induced genetic mutations. Kidney Int. 2012;81(6):529–538. doi: 10.1038/ki.2011.451
   PubMed Web of Science ®Google Scholar
• Cortinovis M, Perico N, Ruggenenti P, et al. Glomerular hyperfiltration. Nat Rev Nephrol. 2022;18(7):435–451. doi: 10.1038/s41581-022-00559-y
   PubMed Web of Science ®Google Scholar
• Sholokh A, Klussmann E. Local cyclic adenosine monophosphate signalling cascades-Roles and targets in chronic kidney disease. Acta Physiol (Oxf). 2021;232(1):e13641. doi: 10.1111/apha.13641
   PubMed Web of Science ®Google Scholar
• Yamaguchi T, Pelling JC, Ramaswamy NT, et al. cAMP stimulates the in vitro proliferation of renal cyst epithelial cells by activating the extracellular signal-regulated kinase pathway. Kidney Int. 2000;57(4):1460–1471. doi: 10.1046/j.1523-1755.2000.00991.x
   PubMed Web of Science ®Google Scholar
• Yasuda G, Jeffries WB. Regulation of cAMP production in initial and terminal inner medullary collecting ducts. Kidney Int. 1998;54(1):80–86. doi: 10.1046/j.1523-1755.1998.00990.x
   PubMed Web of Science ®Google Scholar
• Gattone VH 2nd, Wang X, Harris PC, et al. Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist. Nat Med. 2003;9(10):1323–1326. doi: 10.1038/nm935
   PubMed Web of Science ®Google Scholar
• Boertien WE, Meijer E, de Jong PE, et al. Short-term renal hemodynamic effects of tolvaptan in subjects with autosomal dominant polycystic kidney disease at various stages of chronic kidney disease. Kidney Int. 2013;84(6):1278–1286. doi: 10.1038/ki.2013.285
   PubMed Web of Science ®Google Scholar
• Horie S, Muto S, Kawano H, et al. Preservation of kidney function irrelevant of total kidney volume growth rate with tolvaptan treatment in patients with autosomal dominant polycystic kidney disease. Clin Exp Nephrol. 2021;25(5):467–478. doi: 10.1007/s10157-020-02009-0
   PubMed Web of Science ®Google Scholar
• Palmer LG, Schnermann J. Integrated control of Na transport along the nephron. Clin J Am Soc Nephrol. 2015;10(4):676–687. doi: 10.2215/CJN.12391213
   PubMed Web of Science ®Google Scholar
• Giménez I, Forbush B. Short-term stimulation of the renal Na-K-Cl cotransporter (NKCC2) by vasopressin involves phosphorylation and membrane translocation of the protein. J Biol Chem. 2003;278(29):26946–26951. doi: 10.1074/jbc.M303435200
   PubMed Web of Science ®Google Scholar
• Caceres PS, Mendez M, Ortiz PA. Vesicle-associated membrane protein 2 (VAMP2) but Not VAMP3 mediates cAMP-stimulated trafficking of the renal Na±K±2Cl- co-transporter NKCC2 in thick ascending limbs. J Biol Chem. 2014;289(34):23951–23962. doi: 10.1074/jbc.M114.589333
   PubMed Web of Science ®Google Scholar
• Caceres PS, Mendez M, Haque MZ, et al. Vesicle-associated membrane protein 3 (VAMP3) mediates constitutive trafficking of the Renal Co-transporter NKCC2 in thick ascending limbs: role in renal function and blood pressure. J Biol Chem. 2016;291(42):22063–22073. doi: 10.1074/jbc.M116.735167
   PubMed Web of Science ®Google Scholar
• Fraser SA, Gimenez I, Cook N, et al. Regulation of the renal-specific Na±K±2Cl- co-transporter NKCC2 by AMP-activated protein kinase (AMPK). Biochem J. 2007;405(1):85–93. doi: 10.1042/BJ20061850
   PubMedGoogle Scholar
• Richardson C, Sakamoto K, de Los Heros P, et al. Regulation of the NKCC2 ion cotransporter by SPAK-OSR1-dependent and -independent pathways. J Cell Sci. 2011;124(Pt 5):789–800. doi: 10.1242/jcs.077230
   PubMed Web of Science ®Google Scholar
• Gunaratne R, Braucht DW, Rinschen MM, et al. Quantitative phosphoproteomic analysis reveals cAMP/vasopressin-dependent signaling pathways in native renal thick ascending limb cells. Proc Natl Acad Sci USA. 2010;107(35):15653–15658. doi: 10.1073/pnas.1007424107
   PubMed Web of Science ®Google Scholar
• Nonoguchi H, Owada A, Kobayashi N, et al. Immunohistochemical localization of V2 vasopressin receptor along the nephron and functional role of luminal V2 receptor in terminal inner medullary collecting ducts. J Clin Invest. 1995;96(4):1768–1778. doi: 10.1172/JCI118222
   PubMed Web of Science ®Google Scholar
• Terada Y, Tomita K, Nonoguchi H, et al. Different localization and regulation of two types of vasopressin receptor messenger RNA in microdissected rat nephron segments using reverse transcription polymerase chain reaction. J Clin Invest. 1993;92(5):2339–2345. doi: 10.1172/JCI116838
   PubMed Web of Science ®Google Scholar
• Mutig K, Paliege A, Kahl T, et al. Vasopressin V2 receptor expression along rat, mouse, and human renal epithelia with focus on TAL. Am J Physiol Renal Physiol. 2007;293(4):F1166–77. doi: 10.1152/ajprenal.00196.2007
   PubMed Web of Science ®Google Scholar
• Mutig K, Borowski T, Boldt C, et al. Demonstration of the functional impact of vasopressin signaling in the thick ascending limb by a targeted transgenic rat approach. Am J Physiol Renal Physiol. 2016;311(2):F411–23. doi: 10.1152/ajprenal.00126.2016
   PubMed Web of Science ®Google Scholar
• Rieg T, Tang T, Uchida S, et al. Adenylyl cyclase 6 enhances NKCC2 expression and mediates vasopressin-induced phosphorylation of NKCC2 and NCC. Am J Pathol. 2013;182(1):96–106. doi: 10.1016/j.ajpath.2012.09.014
   PubMed Web of Science ®Google Scholar
• Jesus Ferreira MC D, Bailly C. Extracellular Ca2+ decreases chloride reabsorption in rat CTAL by inhibiting cAMP pathway. Am J Physiol. 1998;275(2):F198–F203. doi: 10.1152/ajprenal.1998.275.2.F198
   PubMedGoogle Scholar
• Edwards ME, Chebib FT, Irazabal MV, et al. Long-term administration of tolvaptan in autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol. 2018;13(8):1153–1161. doi: 10.2215/CJN.01520218
   PubMed Web of Science ®Google Scholar
• Higashihara E, Nutahara K, Itoh M, et al. Long-term outcomes of longitudinal efficacy study with tolvaptan in autosomal dominant polycystic kidney disease. Kidney Int Rep. 2022;7(2):270–281. doi: 10.1016/j.ekir.2021.11.034
   PubMedGoogle Scholar
• Beierwaltes WH. The role of calcium in the regulation of renin secretion. Am J Physiol Renal Physiol. 2010;298(1):F1–F11. doi: 10.1152/ajprenal.00143.2009
   PubMed Web of Science ®Google Scholar
• Lorenzi T, Graciotti L, Sagrati A, et al. Normal human macula densa morphology and cell turnover: a histological, ultrastructural, and immunohistochemical investigation. Anat Rec. 2020;303(11):2904–2916. doi: 10.1002/ar.24465
   Google Scholar
• Romero CA, Carretero OA. Tubule-vascular feedback in renal autoregulation. Am J Physiol Renal Physiol. 2019;316(6):F1218–26. doi: 10.1152/ajprenal.00381.2018
   PubMed Web of Science ®Google Scholar
• Castrop H, Schiessl IM. Physiology and pathophysiology of the renal Na-K-2Cl cotransporter (NKCC2). Am J Physiol Renal Physiol. 2014;307(9):F991–F1002. doi: 10.1152/ajprenal.00432.2014
   PubMed Web of Science ®Google Scholar
• Peti-Peterdi J, Chambrey R, Bebok Z, et al. Macula densa Na(+)/H(+) exchange activities mediated by apical NHE2 and basolateral NHE4 isoforms. Am J Physiol Renal Physiol. 2000;278(3):F452–63. doi: 10.1152/ajprenal.2000.278.3.F452
   PubMed Web of Science ®Google Scholar
• Wang WH. Regulation of ROMK (Kir1.1) channels: new mechanisms and aspects. Am J Physiol Renal Physiol. 2006;290(1):F14–9. doi: 10.1152/ajprenal.00093.2005
   PubMed Web of Science ®Google Scholar
• Peti-Peterdi J, Bebok Z, Lapointe JY, et al. Novel regulation of cell [Na(+)] in macula densa cells: apical Na(+) recycling by H-K-ATPase. Am J Physiol Renal Physiol. 2002;282(2):F324–9. doi: 10.1152/ajprenal.00251.2001
   PubMed Web of Science ®Google Scholar
• Reilly RF, Ellison DH. Mammalian distal tubule: physiology, pathophysiology, and molecular anatomy. Physiol Rev. 2000;80(1):277–313. doi: 10.1152/physrev.2000.80.1.277
   PubMed Web of Science ®Google Scholar
• Briggs JP. A simple steady-state model for feedback control of glomerular filtration rate. Kidney Int Suppl. 1982;12:S143–S150.
   PubMedGoogle Scholar
• Peti-Peterdi J, Morishima S, Bell PD, et al. Two-photon excitation fluorescence imaging of the living juxtaglomerular apparatus. Am J Physiol Renal Physiol. 2002;283(1):F197–F201. doi: 10.1152/ajprenal.00356.2001
   PubMed Web of Science ®Google Scholar
• Thomson S, Vallon V, Blantz RC. Asymmetry of tubuloglomerular feedback effector mechanism with respect to ambient tubular flow. Am J Physiol. 1996;271(6 Pt 2):F1123–30. doi: 10.1152/ajprenal.1996.271.6.F1123
   PubMedGoogle Scholar
• Ren Y, Garvin JL, Carretero OA. Efferent arteriole tubuloglomerular feedback in the renal nephron. Kidney Int. 2001;59(1):222–229. doi: 10.1046/j.1523-1755.2001.00482.x
   PubMed Web of Science ®Google Scholar
• Wright FS, Schnermann J. Interference with feedback control of glomerular filtration rate by furosemide, triflocin, and cyanide. J Clin Invest. 1974;53(6):1695–1708. doi: 10.1172/JCI107721
   PubMed Web of Science ®Google Scholar
• Gimenez I, Isenring P, Forbush B. Spatially distributed alternative splice variants of the renal Na-K-Cl cotransporter exhibit dramatically different affinities for the transported ions. J Biol Chem. 2002;277(11):8767–8770. doi: 10.1074/jbc.C200021200
   PubMed Web of Science ®Google Scholar
• Plata C, Meade P, Vazquez N, et al. Functional properties of the apical Na±K±2Cl- cotransporter isoforms. J Biol Chem. 2002;277(13):11004–11012. doi: 10.1074/jbc.M110442200
   PubMed Web of Science ®Google Scholar
• Schiessl IM, Rosenauer A, Kattler V, et al. Dietary salt intake modulates differential splicing of the Na-K-2Cl cotransporter NKCC2. Am J Physiol Renal Physiol. 2013;305(8):F1139–48. doi: 10.1152/ajprenal.00259.2013
   PubMed Web of Science ®Google Scholar
• Oppermann M, Mizel D, Huang G, et al. Macula densa control of renin secretion and preglomerular resistance in mice with selective deletion of the B isoform of the Na,K,2Cl co-transporter. J Am Soc Nephrol. 2006;17(8):2143–2152. doi: 10.1681/ASN.2006040384
   PubMed Web of Science ®Google Scholar
• Oppermann M, Mizel D, Kim SM, et al. Renal function in mice with targeted disruption of the a isoform of the Na-K-2Cl co-transporter. J Am Soc Nephrol. 2007;18(2):440–448. doi: 10.1681/ASN.2006091070
   PubMed Web of Science ®Google Scholar
• Beach RE, Watts BA 3rd, Good DW, et al. Effects of graded oxygen tension on adenosine release by renal medullary and thick ascending limb suspensions. Kidney Intern. 1991;39(5):836–842. doi: 10.1038/ki.1991.105
   PubMed Web of Science ®Google Scholar
• Vallon V, Osswald H. Adenosine receptors and the kidney. In: Wilson C Mustafa S, editors. Adenosine receptors in health and disease. Handbook of experimental pharmacology. Vol. 193. Berlin (Heidelberg): Springer; 2009. p. 443–470.
   Google Scholar
• Brown R, Ollerstam A, Johansson B, et al. Abolished tubuloglomerular feedback and increased plasma renin in adenosine A1 receptor-deficient mice. Am J Physiol Regul Integr Comp Physiol. 2001;281(5):R1362–67. doi: 10.1152/ajpregu.00470.2001
   PubMed Web of Science ®Google Scholar
• Touyz RM, Alves-Lopes R, Rios FJ, et al. Vascular smooth muscle contraction in hypertension. Cardiovasc Res. 2018;114(4):529–539. doi: 10.1093/cvr/cvy023
   PubMed Web of Science ®Google Scholar
• Francis SH, Busch JL, Corbin JD, et al. cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action. Pharmacol Rev. 2010;62(3):525–563. doi: 10.1124/pr.110.002907
   PubMed Web of Science ®Google Scholar
• Li L, Lai EY, Huang Y, et al. Renal afferent arteriolar and tubuloglomerular feedback reactivity in mice with conditional deletions of adenosine 1 receptors. Am J Physiol Renal Physiol. 2012;303(8):F1166–75. doi: 10.1152/ajprenal.00222.2012
   PubMed Web of Science ®Google Scholar
• Carlström M, Wilcox CS, Welch WJ. Adenosine A2A receptor activation attenuates tubuloglomerular feedback responses by stimulation of endothelial nitric oxide synthase. Am J Physiol Renal Physiol. 2011;300(2):F457–64. doi: 10.1152/ajprenal.00567.2010
   PubMed Web of Science ®Google Scholar
• Nishiyama A, Inscho EW, Navar LG. Interactions of adenosine A1 and A2a receptors on renal microvascular reactivity. Am J Physiol Renal Physiol. 2001;280(3):F406–14. doi: 10.1152/ajprenal.2001.280.3.F406
   PubMed Web of Science ®Google Scholar
• Lai EY, Patzak A, Steege A, et al. Contribution of adenosine receptors in the control of arteriolar tone and adenosine-angiotensin II interaction. Kidney Int. 2006;70(4):690–698. doi: 10.1038/sj.ki.5001650
   PubMed Web of Science ®Google Scholar
• Liu R, Carretero OA, Ren Y, et al. Increased intracellular pH at the macula densa activates nNOS during tubuloglomerular feedback. Kidney Int. 2005;67(5):1837–1843. doi: 10.1111/j.1523-1755.2005.00282.x
   PubMed Web of Science ®Google Scholar
• Wang H, Carretero OA, Garvin JL. Inhibition of apical Na+/H+ exchangers on the macula densa cells augments tubuloglomerular feedback. Hypertension. 2003;41(3 Pt 2):688–691. doi: 10.1161/01.HYP.0000048863.75711.B2
   PubMed Web of Science ®Google Scholar
• Wang L, Shen C, Liu H, et al. Shear stress blunts tubuloglomerular feedback partially mediated by primary cilia and nitric oxide at the macula densa. Am J Physiol Regul Integr Comp Physiol. 2015;309(7):R757–66. doi: 10.1152/ajpregu.00173.2015
   PubMed Web of Science ®Google Scholar
• Zhang J, Wei J, Jiang S, et al. Macula densa SGLT1-NOS1-tubuloglomerular feedback pathway, a new mechanism for glomerular hyperfiltration during hyperglycemia. J Am Soc Nephrol. 2019;30(4):578–593. doi: 10.1681/ASN.2018080844
   PubMed Web of Science ®Google Scholar
• Lorenz JN, Dostanic-Larson I, Shull GE, et al. Ouabain inhibits tubuloglomerular feedback in mutant mice with ouabain-sensitive alpha1 Na,K-ATPase. J Am Soc Nephrol. 2006;17(9):2457–2463. doi: 10.1681/ASN.2006040379
   PubMed Web of Science ®Google Scholar
• Kovacs G, Komlosi P, Fuson A, et al. Neuronal nitric oxide synthase: its role and regulation in macula densa cells. J Am Soc Nephrol. 2003;14(10):2475–2483. doi: 10.1097/01.ASN.0000088737.05283.2B
   PubMed Web of Science ®Google Scholar
• Thomson SC. Nitric oxide mediates anomalous tubuloglomerular feedback in rats fed high-NaCl diet after subtotal nephrectomy. Am J Physiol Renal Physiol. 2019;316(2):F223–30. doi: 10.1152/ajprenal.00066.2018
   PubMed Web of Science ®Google Scholar
• de Gasparo M, Catt KJ, Inagami T, et al. International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev. 2000;52(3):415–472.
   PubMed Web of Science ®Google Scholar
• Schrankl J, Fuchs M, Broeker K, et al. Localization of angiotensin II type 1 receptor gene expression in rodent and human kidneys. Am J Physiol Renal Physiol. 2021;320(4):F644–53. doi: 10.1152/ajprenal.00550.2020
   PubMed Web of Science ®Google Scholar
• Patzak A, Lai EY, Fahling M, et al. Adenosine enhances long term the contractile response to angiotensin II in afferent arterioles. Am J Physiol Regul Integr Comp Physiol. 2007;293(6):R2232–42. doi: 10.1152/ajpregu.00357.2007
   PubMed Web of Science ®Google Scholar
• Sedeek M, Nasrallah R, Touyz RM, et al. NADPH oxidases, reactive oxygen species, and the kidney: friend and foe. J Am Soc Nephrol. 2013;24(10):1512–1518. doi: 10.1681/ASN.2012111112
   PubMed Web of Science ®Google Scholar
• Liu R, Juncos LA. GTPase-rac enhances depolarization-induced superoxide production by the macula densa during tubuloglomerular feedback. Am J Physiol Regul Integr Comp Physiol. 2010;298(2):R453–8. doi: 10.1152/ajpregu.00622.2009
   PubMed Web of Science ®Google Scholar
• Liu R, Carretero OA, Ren Y, et al. Intracellular pH regulates superoxide production by the macula densa. Am J Physiol Renal Physiol. 2008;295(3):F851–6. doi: 10.1152/ajprenal.90204.2008
   PubMed Web of Science ®Google Scholar
• Zhang J, Chandrashekar K, Lu Y, et al. Enhanced expression and activity of Nox2 and Nox4 in the macula densa in ANG II-induced hypertensive mice. Am J Physiol Renal Physiol. 2014;306(3):F344–50. doi: 10.1152/ajprenal.00515.2013
   PubMed Web of Science ®Google Scholar
• Zhu X, Rd M Jr, Lu D, et al. Aldosterone stimulates superoxide production in macula densa cells. Am J Physiol Renal Physiol. 2011;301(3):F529–35. doi: 10.1152/ajprenal.00596.2010
   PubMed Web of Science ®Google Scholar
• Liu R, Ren Y, Garvin JL, et al. Superoxide enhances tubuloglomerular feedback by constricting the afferent arteriole. Kidney Int. 2004;66(1):268–274. doi: 10.1111/j.1523-1755.2004.00727.x
   PubMed Web of Science ®Google Scholar
• Ren Y, Garvin JL, Liu R, et al. Crosstalk between the connecting tubule and the afferent arteriole regulates renal microcirculation. Kidney Int. 2007;71(11):1116–1121. doi: 10.1038/sj.ki.5002190
   PubMed Web of Science ®Google Scholar
• Ren Y, D’Ambrosio MA, Garvin JL, et al. Prostaglandin E2 mediates connecting tubule glomerular feedback. Hypertension. 2013;62(6):1123–1128. doi: 10.1161/HYPERTENSIONAHA.113.02040
   PubMed Web of Science ®Google Scholar
• Schweda F, Klar J, Narumiya S, et al. Stimulation of renin release by prostaglandin E2 is mediated by EP2 and EP4 receptors in mouse kidneys. Am J Physiol Renal Physiol. 2004;287(3):F427–33. doi: 10.1152/ajprenal.00072.2004
   PubMed Web of Science ®Google Scholar
• Ren Y, D’Ambrosio MA, Wang H, et al. Mechanisms of angiotensin II-enhanced connecting tubule glomerular feedback. Am J Physiol Renal Physiol. 2012;303(2):F259–65. doi: 10.1152/ajprenal.00689.2011
   PubMed Web of Science ®Google Scholar
• Ren Y, Janic B, Kutskill K, et al. Mechanisms of connecting tubule glomerular feedback enhancement by aldosterone. Am J Physiol Renal Physiol. 2016;311(6):F1182–8. doi: 10.1152/ajprenal.00076.2016
   PubMed Web of Science ®Google Scholar
• Kurtz A. Control of renin synthesis and secretion. Am J Hypertens. 2012;25(8):839–847. doi: 10.1038/ajh.2011.246
   PubMed Web of Science ®Google Scholar
• Castrop H, Hocherl K, Kurtz A, et al. Physiology of kidney renin. Physiol Rev. 2010;90(2):607–673. doi: 10.1152/physrev.00011.2009
   PubMed Web of Science ®Google Scholar
• Sequeira-Lopez MLS, Gomez RA. Renin cells, the kidney, and hypertension. Circ Res. 2021;128(7):887–907. doi: 10.1161/CIRCRESAHA.121.318064
   PubMed Web of Science ®Google Scholar
• Kim SM, Chen L, Faulhaber-Walter R, et al. Regulation of renin secretion and expression in mice deficient in beta1- and beta2-adrenergic receptors. Hypertension. 2007;50(1):103–109. doi: 10.1161/HYPERTENSIONAHA.107.087577
   PubMed Web of Science ®Google Scholar
• Aldehni F, Tang T, Madsen K, et al. Stimulation of renin secretion by catecholamines is dependent on adenylyl cyclases 5 and 6. Hypertension. 2011;57(3):460–468. doi: 10.1161/HYPERTENSIONAHA.110.167130
   PubMed Web of Science ®Google Scholar
• Ortiz-Capisano MC, Liao TD, Ortiz PA, et al. Calcium-dependent phosphodiesterase 1C inhibits renin release from isolated juxtaglomerular cells. Am J Physiol Regul Integr Comp Physiol. 2009;297(5):R1469–76. doi: 10.1152/ajpregu.00121.2009
   PubMed Web of Science ®Google Scholar
• Madsen K, Friis UG, Gooch JL, et al. Inhibition of calcineurin phosphatase promotes exocytosis of renin from juxtaglomerular cells. Kidney Int. 2010;77(2):110–117. doi: 10.1038/ki.2009.418
   PubMed Web of Science ®Google Scholar
• Gomez RA, Sequeira-Lopez MLS. Renin cells in homeostasis, regeneration and immune defence mechanisms. Nat Rev Nephrol. 2018;14(4):231–245. doi: 10.1038/nrneph.2017.186
   PubMed Web of Science ®Google Scholar
• Mendez M, Gross KW, Glenn ST, et al. Vesicle-associated membrane protein-2 (VAMP2) mediates cAMP-stimulated renin release in mouse juxtaglomerular cells. J Biol Chem. 2011;286(32):28608–28618. doi: 10.1074/jbc.M111.225839
   PubMed Web of Science ®Google Scholar
• Mendez M, Gaisano HY. Role of the SNARE protein SNAP23 on cAMP-stimulated renin release in mouse juxtaglomerular cells. Am J Physiol Renal Physiol. 2013;304(5):F498–04. doi: 10.1152/ajprenal.00556.2012
   PubMed Web of Science ®Google Scholar
• Mendez M. Renin release: role of SNAREs. Am J Physiol Regul Integr Comp Physiol. 2014;307(5):R484–6. doi: 10.1152/ajpregu.00175.2014
   PubMed Web of Science ®Google Scholar
• Ortiz-Capisano MC, Ortiz PA, Garvin JL, et al. Expression and function of the calcium-sensing receptor in juxtaglomerular cells. Hypertension. 2007;50(4):737–743. doi: 10.1161/HYPERTENSIONAHA.107.095158
   PubMed Web of Science ®Google Scholar
• Ortiz-Capisano MC, Reddy M, Mendez M, et al. Juxtaglomerular cell CaSR stimulation decreases renin release via activation of the PLC/IP(3) pathway and the ryanodine receptor. Am J Physiol Renal Physiol. 2013;304(3):F248–56. doi: 10.1152/ajprenal.00451.2012
   PubMed Web of Science ®Google Scholar
• Vallon V, Muhlbauer B, Osswald H. Adenosine and kidney function. Physiol Rev. 2006;86(3):901–940. doi: 10.1152/physrev.00031.2005
   PubMed Web of Science ®Google Scholar
• Schweda F, Segerer F, Castrop H, et al. Blood pressure-dependent inhibition of renin secretion requires A1 adenosine receptors. Hypertension. 2005;46(4):780–786. doi: 10.1161/01.HYP.0000183963.07801.65
   PubMed Web of Science ®Google Scholar
• Schweda F, Wagner C, Kramer BK, et al. Preserved macula densa-dependent renin secretion in A1 adenosine receptor knockout mice. Am J Physiol Renal Physiol. 2003;284(4):F770–7. doi: 10.1152/ajprenal.00280.2002
   PubMed Web of Science ®Google Scholar
• Sayago CM, Beierwaltes WH. Nitric oxide synthase and cGMP-mediated stimulation of renin secretion. Am J Physiol Regul Integr Comp Physiol. 2001;281(4):R1146–51. doi: 10.1152/ajpregu.2001.281.4.R1146
   PubMed Web of Science ®Google Scholar
• Kurtz A, Gotz KH, Hamann M, et al. Stimulation of renin secretion by nitric oxide is mediated by phosphodiesterase 3. Proc Natl Acad Sci USA. 1998;95(8):4743–4747. doi: 10.1073/pnas.95.8.4743
   PubMed Web of Science ®Google Scholar
• Gambaryan S, Wagner C, Smolenski A, et al. Endogenous or overexpressed cGMP-dependent protein kinases inhibit cAMP-dependent renin release from rat isolated perfused kidney, microdissected glomeruli, and isolated juxtaglomerular cells. Proc Natl Acad Sci USA. 1998;95(15):9003–9008. doi: 10.1073/pnas.95.15.9003
   PubMed Web of Science ®Google Scholar
• Yang T, Park JM, Arend L, et al. Low chloride stimulation of prostaglandin E2 release and cyclooxygenase-2 expression in a mouse macula densa cell line. J Biol Chem. 2000;275(48):37922–37929. doi: 10.1074/jbc.M006218200
   PubMed Web of Science ®Google Scholar
• Cheng HF, Wang JL, Zhang MZ, et al. Role of p38 in the regulation of renal cortical cyclooxygenase-2 expression by extracellular chloride. J Clin Invest. 2000;106(5):681–688. doi: 10.1172/JCI10318
   PubMed Web of Science ®Google Scholar
• Watanabe H, Belyea BC, Paxton RL, et al. Renin cell baroreceptor, a nuclear mechanotransducer central for homeostasis. Circ Res. 2021;129(2):262–276. doi: 10.1161/CIRCRESAHA.120.318711
   PubMed Web of Science ®Google Scholar
• DiBona GF, Kopp UC. Neural control of renal function. Physiol Rev. 1997;77(1):75–197. doi: 10.1152/physrev.1997.77.1.75
   PubMed Web of Science ®Google Scholar
• Loffing J, Kaissling B. Sodium and calcium transport pathways along the mammalian distal nephron: from rabbit to human. Am J Physiol Renal Physiol. 2003;284(4):F628–43. doi: 10.1152/ajprenal.00217.2002
   PubMed Web of Science ®Google Scholar
• Mount DB. Transport of sodium, chloride, and potassium. In: Skorecki K, Chertow G Marsden P, editors, et al. Brenner and rector’s the kidney. 10th ed. Amsterdam: Elsevier; 2015.
   Google Scholar
• Beutler KT, Masilamani S, Turban S, et al. Long-term regulation of ENaC expression in kidney by angiotensin II. Hypertension. 2003;41(5):1143–1150. doi: 10.1161/01.HYP.0000066129.12106.E2
   PubMed Web of Science ®Google Scholar
• Brooks HL, Allred AJ, Beutler KT, et al. Targeted proteomic profiling of renal Na(+) transporter and channel abundances in angiotensin II type 1a receptor knockout mice. Hypertension. 2002;39(2 Pt 2):470–473. doi: 10.1161/hy02t2.102959
   PubMed Web of Science ®Google Scholar
• Spat A, Hunyady L. Control of aldosterone secretion: a model for convergence in cellular signaling pathways. Physiol Rev. 2004;84(2):489–539. doi: 10.1152/physrev.00030.2003
   PubMed Web of Science ®Google Scholar
• Gonzalez AA, Liu L, Lara LS, et al. PKC-alpha-dependent augmentation of cAMP and CREB phosphorylation mediates the angiotensin II stimulation of renin in the collecting duct. Am J Physiol Renal Physiol. 2015;309(10):F880–8. doi: 10.1152/ajprenal.00155.2015
   PubMed Web of Science ®Google Scholar
• Prieto MC, Gonzalez AA, Visniauskas B, et al. The evolving complexity of the collecting duct renin-angiotensin system in hypertension. Nat Rev Nephrol. 2021;17(7):481–492. doi: 10.1038/s41581-021-00414-6
   PubMed Web of Science ®Google Scholar
• Evans RG, Gardiner BS, Smith DW, et al. Intrarenal oxygenation: unique challenges and the biophysical basis of homeostasis. Am J Physiol Renal Physiol. 2008;295(5):F1259–70. doi: 10.1152/ajprenal.90230.2008
   PubMed Web of Science ®Google Scholar
• Ren Y, D’Ambrosio MA, Garvin JL, et al. Angiotensin II enhances connecting tubule glomerular feedback. Hypertension. 2010;56(4):636–642. doi: 10.1161/HYPERTENSIONAHA.110.153692
   PubMed Web of Science ®Google Scholar
• Singh P, Deng A, Blantz RC, et al. Unexpected effect of angiotensin AT1 receptor blockade on tubuloglomerular feedback in early subtotal nephrectomy. Am J Physiol Renal Physiol. 2009;296(5):F1158–65. doi: 10.1152/ajprenal.90722.2008
   PubMed Web of Science ®Google Scholar
• Hostetter TH, Olson JL, Rennke HG, et al. Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation. Am J Physiol. 1981;241(1):F85–F93. doi: 10.1152/ajprenal.1981.241.1.F85
   PubMed Web of Science ®Google Scholar
• Cao W, Li A, Wang L, et al. A salt-induced reno-cerebral reflex activates renin-angiotensin systems and promotes CKD progression. J Am Soc Nephrol. 2015;26(7):1619–1633. doi: 10.1681/ASN.2014050518
   PubMed Web of Science ®Google Scholar
• Perkovic V, Jardine MJ, Neal B, et al. Canagliflozin and renal outcomes in type 2 diabetes and nephropathy. N Engl J Med. 2019;380(24):2295–2306. doi: 10.1056/NEJMoa1811744
   PubMed Web of Science ®Google Scholar
• Heerspink HJL, Kosiborod M, Inzucchi SE, et al. Renoprotective effects of sodium-glucose cotransporter-2 inhibitors. Kidney Int. 2018;94(1):26–39. doi: 10.1016/j.kint.2017.12.027
   PubMed Web of Science ®Google Scholar
• Palmer BF, Clegg DJ. Kidney-protective effects of SGLT2 inhibitors. Clin J Am Soc Nephrol. 2023;18(2):279–289. doi: 10.2215/CJN.09380822
   PubMed Web of Science ®Google Scholar
• Bakris G, Oshima M, Mahaffey KW, et al. Effects of canagliflozin in patients with baseline eGFR <30 ml/min per 1.73 m2: subgroup analysis of the randomized CREDENCE trial. Clin J Am Soc Nephrol. 2020;15(12):1705–1714. doi: 10.2215/CJN.10140620
   PubMed Web of Science ®Google Scholar
• Chertow GM, Vart P, Jongs N, et al. Effects of dapagliflozin in stage 4 chronic kidney disease. J Am Soc Nephrol. 2021;32(9):2352–2361. doi: 10.1681/ASN.2021020167
   PubMed Web of Science ®Google Scholar
• Torres VE, Chapman AB, Devuyst O, et al. Tolvaptan in later-stage autosomal dominant polycystic kidney disease. N Engl J Med. 2017;377(20):1930–1942. doi: 10.1056/NEJMoa1710030
   PubMed Web of Science ®Google Scholar